Literature DB >> 28931242

Pfhrp2 Deletions in the Democratic Republic of Congo: Evidence of Absence, or Absence of Evidence?

Charles J Woodrow1,2, Caterina Fanello1,2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28931242      PMCID: PMC5853314          DOI: 10.1093/infdis/jix345

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
To the Editor—Parr et al report that Plasmodium falciparum parasites with deletion of the pfhrp2 gene can be found in children across all provinces of the Democratic Republic of Congo [1]. It is possible to differentiate gene deletion from other causes of a negative P. falciparum histidine-rich protein 2 (PfHRP2)–based rapid diagnostic test via a series of investigations [2, 3], starting with positive microscopic identification of P. falciparum, a straightforward way of minimizing at the outset the chance that the gene cannot be detected simply because of low levels of DNA [4]. Parr et al used many of these recommended steps, and the work was clearly undertaken to a high technical standard, but a distinct feature of the study was that the diagnosis of P. falciparum was determined by real-time polymerase chain reaction (PCR) detection of pfldh, a relatively sensitive approach designed to capture all pfhrp2-deleted parasites. The article comes to a confident conclusion that the pfhrp2-negative PCR results represent gene deletion rather than insufficient DNA. Was this confidence justified? The answer, in our view, is a clear “no.” Unsurprisingly, a large proportion (90%) of the “pfhrp2-deleted” samples were negative on microscopy. In a set of samples where parasitemia is generally below the level of microscopic detection, successful PCR amplification of a control gene does not guarantee that another gene will be robustly amplified from the same sample. Borderline DNA concentrations will cause stochastic failure of individual PCR reactions, so samples negative by PCR for pfhrp2 but positive for other genes and, hence, fulfilling the study’s criteria for “pfhrp2 deletion,” will be inevitable simply because of the number of samples studied. The potential for overcalling “deletions” gets even worse if any of the positive control PCR reactions are more sensitive than the test reactions. No data on relative sensitivity of the pfhrp2 and control gene reactions were provided (in fact, optimal conditions were explored during the course of the study). However, there is evidence for differential sensitivity of the 2 pfhrp2 PCR reactions. Of the 91 samples positive for only 1 of the 2 pfhrp2 sequences (calculated from supplementary data), most (80) were positive at exon 1/2, with 11 positive at exon 2. The obvious explanation for this, with DNA limiting, is that the exon 1/2 PCR had greater sensitivity: it involved nested primers and a 308-bp amplicon whereas the PCR for exon 2 involved a single pair of primers and a longer amplicon (Table 1), both factors associated with reduced PCR efficiency [5]. Instead, it is simply assumed that all these isolates represent partial pfhrp2 deletions, despite the absence of reports of such parasites in large surveys [6, 7].
Table 1.

Characteristics of Polymerase Chain Reaction Assays Used in the Study of Parr et al

Sequence, SectionLength in Genome (Outer Primers)Polymerase Chain Reaction Type
pfhrp2, exon 1/2308Nested
pfhrp2, exon 2842Single pair of primers
pfhrp3, exon 1/2301Single pair of primers
pfhrp3, exon 2719Heminested
β-tubulin77Single pair of primers
pfldh a Not applicableReal-time

aPositive result used as entry criterion to study.

Characteristics of Polymerase Chain Reaction Assays Used in the Study of Parr et al aPositive result used as entry criterion to study. In addition, there was an intrinsic bias in study design. For a sample to avoid the classification “pfhrp2 deleted,” both pfhrp2 sections had to be amplified. But subsequent “confirmation” of sufficient DNA required that only 1 of 3 control PCR sequences be amplified (2 sections of pfhrp3 and β-tubulin). The authors state that of “149 pfhrp2-deleted P. falciparum isolates, only 5 (3.4%) had co-existing complete pfhrp3 deletions,” but this is the wrong comparison—to interpret the data properly, we need to know how many samples had negative results for either of the pfhrp3 sections (the standard applied for pfhrp2). Although this was not directly determined (control PCR assays were undertaken serially until a positive was obtained), the supplementary data show that the first pfhrp3 PCR failed in 73 cases, again indicating broadly low levels of DNA. The finding that a subset of samples with “pfhrp2 deletion” had a higher proportion of PCR failures at 2 neighboring microsatellite markers is offered as further evidence for gene deletion. Again, the evidence that this was not simply due to low DNA concentrations is not compelling. Markers were approximately evenly amplified in control samples, but these are likely to have had substantially higher levels of DNA. The lower DNA levels that were certainly present in the pfhrp2-negative samples could have exposed lower PCR efficiency at 2 particular markers. Notably, these markers are on the opposite side of the pfhrp2 gene compared with markers absent in pfhrp2-deleted parasites from Latin America [8]. In summary, the concern that many, and possibly all, of the “deletion” samples are just samples with low levels of DNA is never satisfactorily dispelled. This is a much more plausible explanation for their ubiquitous distribution across the country. For these reasons, calls for alternatives to PfHRP2 as a diagnostic antigen in this region are not yet indicated.
  7 in total

1.  Technical report: Part 2. Basic requirements for designing optimal PCR primers.

Authors:  M Mitsuhashi
Journal:  J Clin Lab Anal       Date:  1996       Impact factor: 2.352

2.  Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey.

Authors:  Jonathan B Parr; Robert Verity; Stephanie M Doctor; Mark Janko; Kelly Carey-Ewend; Breanna J Turman; Corinna Keeler; Hannah C Slater; Amy N Whitesell; Kashamuka Mwandagalirwa; Azra C Ghani; Joris L Likwela; Antoinette K Tshefu; Michael Emch; Jonathan J Juliano; Steven R Meshnick
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

3.  A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests.

Authors:  Dionicia Gamboa; Mei-Fong Ho; Jorge Bendezu; Katherine Torres; Peter L Chiodini; John W Barnwell; Sandra Incardona; Mark Perkins; David Bell; James McCarthy; Qin Cheng
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

4.  Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests.

Authors:  Joanne Baker; Mei-Fong Ho; Anita Pelecanos; Michelle Gatton; Nanhua Chen; Salim Abdullah; Audrey Albertini; Frederic Ariey; John Barnwell; David Bell; Jane Cunningham; Djibrine Djalle; Diego F Echeverry; Dionicia Gamboa; Jeffery Hii; Myat Phone Kyaw; Jennifer Luchavez; Christopher Membi; Didier Menard; Claribel Murillo; Sina Nhem; Bernhards Ogutu; Pamela Onyor; Wellington Oyibo; Shan Qing Wang; James McCarthy; Qin Cheng
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

5.  Comparison of a PfHRP2-based rapid diagnostic test and PCR for malaria in a low prevalence setting in rural southern Zambia: implications for elimination.

Authors:  Natasha M Laban; Tamaki Kobayashi; Harry Hamapumbu; David Sullivan; Sungano Mharakurwa; Philip E Thuma; Clive J Shiff; William J Moss
Journal:  Malar J       Date:  2015-01-28       Impact factor: 2.979

6.  Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests.

Authors:  Awa B Deme; Daniel J Park; Amy K Bei; Ousmane Sarr; Aida Sadikh Badiane; Papa El Hadji Omar Gueye; Ambroise Ahouidi; Omar Ndir; Souleymane Mboup; Dyann F Wirth; Daouda Ndiaye; Sarah K Volkman
Journal:  Malar J       Date:  2014-01-29       Impact factor: 2.979

Review 7.  Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting.

Authors:  Qin Cheng; Michelle L Gatton; John Barnwell; Peter Chiodini; James McCarthy; David Bell; Jane Cunningham
Journal:  Malar J       Date:  2014-07-22       Impact factor: 2.979

  7 in total
  5 in total

1.  Response to Woodrow and Fanello.

Authors:  Jonathan B Parr; Steven R Meshnick
Journal:  J Infect Dis       Date:  2017-08-15       Impact factor: 5.226

2.  Low prevalence of Plasmodium falciparum parasites lacking pfhrp2/3 genes among asymptomatic and symptomatic school-age children in Kinshasa, Democratic Republic of Congo.

Authors:  Sabin S Nundu; Hiroaki Arima; Shirley V Simpson; Ben-Yeddy Abel Chitama; Yannick Bazitama Munyeku; Jean-Jacques Muyembe; Toshihiro Mita; Steve Ahuka; Richard Culleton; Taro Yamamoto
Journal:  Malar J       Date:  2022-04-19       Impact factor: 3.469

3.  Analysis of false-negative rapid diagnostic tests for symptomatic malaria in the Democratic Republic of the Congo.

Authors:  Jonathan B Parr; Eddy Kieto; Fernandine Phanzu; Paul Mansiangi; Kashamuka Mwandagalirwa; Nono Mvuama; Ange Landela; Joseph Atibu; Solange Umesumbu Efundu; Jean W Olenga; Kyaw Lay Thwai; Camille E Morgan; Madeline Denton; Alison Poffley; Jonathan J Juliano; Pomie Mungala; Joris L Likwela; Eric M Sompwe; Eric Rogier; Antoinette K Tshefu; Adrien N'Siala; Albert Kalonji
Journal:  Sci Rep       Date:  2021-03-22       Impact factor: 4.379

4.  Impact of Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions on malaria control worldwide: a systematic review and meta-analysis.

Authors:  Irene Molina-de la Fuente; Andrea Pastor; Zaida Herrador; Agustín Benito; Pedro Berzosa
Journal:  Malar J       Date:  2021-06-22       Impact factor: 2.979

5.  Laboratory Detection of Malaria Antigens: a Strong Tool for Malaria Research, Diagnosis, and Epidemiology.

Authors:  Mateusz Plucinski; Michael Aidoo; Eric Rogier
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.